Matinas BioPharma receives NYSE American non-compliance notice
Matinas BioPharma (MTNB) received a notice of non-compliance with NYSE American continued listing standards.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.